filmov
tv
Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute
Показать описание
0:02:40
Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute
0:49:36
Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention
0:31:25
Multiple Myeloma 101: Diagnosis, Prognosis, and Risk: Nikhil C. Munshi, MD
0:19:09
High-risk myeloma: How and should it be treated differently
0:34:55
Multiple Myeloma Symposium: Diagnosis and Risk Assessment | Dana-Farber Cancer Institute
0:44:53
Update in Multiple Myeloma
0:59:53
Clinical Trials in Multiple Myeloma
0:24:43
Multiple Myeloma Update: Frontline Therapy
0:30:34
#MultipleMyeloma and Its Impact on the Black Community
0:46:35
How is multiple myeloma diagnosed and how do risk factors affect treatment? By Dr. Nikhil Munshi
0:34:42
Multiple Myeloma Symposium: Role of Integrative Therapies | Dana-Farber Cancer Institute
0:37:46
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
0:35:50
Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute
0:47:06
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-Farber
0:46:00
Current and Future Treatment of Multiple Myeloma
0:36:17
Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MD
0:47:18
Diagnosis and Risk Assessment In Multiple Myeloma
0:29:29
Dr. Munshi on diagnosis and risk assessment in multiple myeloma | Dana-Farber Cancer Institute
0:01:40
Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients
0:47:15
Multiple Myeloma
0:01:30
Risk assessment & transplant decisions in multiple myeloma
0:15:42
Best Treatment Options for Transplant Ineligible Myeloma Patients: Doublets-Triplets?
0:33:23
Updates on Managing Bone Disease in Multiple Myeloma
0:24:55
What is multiple myeloma and how to manage symptoms of multiple myeloma? Kathleen Colson, RN
Комментарии